Eli Lilly’s diabetes drugs Mounjaro and Trulicity are in short supply due to heightened demand for the medication, the Food and Drug Administration (FDA) announced recently.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,